119 results
Page 3 of 6
424B5
h1axhds og2mypsxcfb
30 Apr 08
Prospectus supplement for primary offering
12:00am
424B5
aihhggkndgv
25 Apr 08
Prospectus supplement for primary offering
12:00am
424B5
cl08byd
25 Apr 08
Prospectus supplement for primary offering
12:00am
424B5
qhzrc87df9zzkew7xk56
4 Mar 08
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
vyk k32vf2
18 Jan 08
Regulation FD Disclosure
12:00am
8-K
EX-2.1
dko1bpe6
27 Jul 07
Cell Therapeutics, Inc. (CTI) Announces Agreement to Acquire SMi; Gains Global Rights to Brostallicin, in a New Class of Cancer Killing Agents
12:00am
8-K
EX-10.2
rbtsjocyr4k1
18 Sep 06
Development Agreement for Development and Commercialization of
12:00am